Singapore-based firm says acquisition of US specialist in disease-tolerant genetic lines will "bolster SyAqua’s portfolio and open new market opportunities".
Both the Norwegian government and Benchmark Genetics Norway stressed the importance of these concessions in supplying high-biosecurity salmon farmers throughout the year.